DRAM1 Promotes Lysosomal Delivery of Mycobacterium marinum in Macrophages

Adrianna Banducci-Karp1, Jiajun Xie1, Sem A G Engels1

  • 1Institute of Biology Leiden, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands.

Cells
|March 29, 2023
PubMed

Insights

Damage-Regulated Autophagy Modulator 1 (DRAM1) enhances macrophage defense against mycobacteria by promoting their degradation. DRAM1 is crucial for trafficking bacteria to the (auto)phagolysosomal pathway for clearance.

Area of Science:

  • Immunology
  • Cell Biology
  • Microbiology

Background:

  • Damage-Regulated Autophagy Modulator 1 (DRAM1) is an infection-inducible protein with an unclear role in immunity.
  • Previous studies suggest DRAM1 acts as a host resistance factor against mycobacterial infections.

Purpose of the Study:

  • To investigate the cellular mechanisms of DRAM1-mediated defense against intracellular mycobacteria.
  • To elucidate the interaction between DRAM1 and *Mycobacterium marinum* in macrophages.

Main Methods:

  • Studied DRAM1 localization and interaction with *M. marinum* in RAW264.7 macrophages.
  • Utilized LC3, LysoTracker, and LAMP1 markers to track mycobacterial vesicle trafficking.
  • Performed DRAM1 knockdown experiments to assess its role in host defense.

Main Results:

  • DRAM1 localizes to and envelops mycobacteria-containing phagosomes.
  • DRAM1 is essential for recruiting LC3 and acidifying mycobacterial vesicles.
  • DRAM1 knockdown impairs macrophage defense against *M. marinum* infection.
  • Reduced LAMP1 suggests impaired lysosome fusion in DRAM1-knockdown cells.

Conclusions:

  • DRAM1 facilitates the degradation of intracellular mycobacteria via the (auto)phagolysosomal pathway.
  • DRAM1 is a key mediator of macrophage microbicidal capacity against mycobacterial infections.
  • DRAM1 represents a potential therapeutic target for enhancing host resistance to intracellular pathogens.